XML 67 R48.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Financial information regarding the company's reportable segments
Financial information regarding our reporting segments is shown below:
Year Ended December 31,202020192018
Total Sales:
Pharma$1,234,107 $1,100,463 $955,069 
Beauty + Home1,320,988 1,376,027 1,446,231 
Food + Beverage407,435 418,017 386,689 
Total Sales$2,962,530 $2,894,507 $2,787,989 
Less: Intersegment Sales:
Pharma$8,328 $9,412 $417 
Beauty + Home22,837 23,313 19,849 
Food + Beverage2,025 2,050 2,962 
Total Intersegment Sales$33,190 $34,775 $23,228 
Net Sales:
Pharma$1,225,779 $1,091,051 $954,652 
Beauty + Home1,298,151 1,352,714 1,426,382 
Food + Beverage405,410 415,967 383,727 
Net Sales$2,929,340 $2,859,732 $2,764,761 
Adjusted EBITDA (1):
Pharma$428,469 $387,483 $343,706 
Beauty + Home129,299 181,150 185,926 
Food + Beverage71,995 68,108 57,589 
Corporate & Other, unallocated(43,443)(44,406)(36,285)
Acquisition-related costs (2)(6,087)(3,927)(23,770)
Restructuring Initiatives (3)(26,492)(20,472)(63,829)
Depreciation and amortization (4)(220,300)(194,552)(171,747)
Interest Expense(33,244)(35,489)(32,626)
Interest Income958 4,174 7,056 
Income before Income Taxes$301,155 $342,069 $266,020 
Depreciation and Amortization:
Pharma$75,874 $65,590 $51,495 
Beauty + Home95,880 82,778 83,546 
Food + Beverage37,768 35,728 27,467 
Corporate & Other10,778 10,456 9,239 
Depreciation and Amortization$220,300 $194,552 $171,747 
Capital Expenditures:
Pharma$117,835 $89,702 $54,433 
Beauty + Home93,980 96,040 101,371 
Food + Beverage29,956 45,130 41,236 
Corporate & Other15,690 13,933 25,739 
Transfer of Corporate Technology Expenditures (5)(11,507)(2,529)(11,527)
Capital Expenditures$245,954 $242,276 $211,252 
Total Assets:
Pharma$1,549,781 $1,422,815 $1,324,696 
Beauty + Home1,610,058 1,378,292 1,373,816 
Food + Beverage549,270 534,527 501,700 
Corporate & Other280,944 226,485 177,523 
Total Assets$3,990,053 $3,562,119 $3,377,735 
(1)We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring initiatives, acquisition-related costs, and other special items.
(2)Acquisition-related costs include transaction costs and purchase accounting adjustments related to acquisitions and investments (see Note 19 – Acquisitions and Note 20 – Investments in Equity Securities for further details).
(3)Restructuring Initiatives includes expense items for the years ended December 31, 2020, 2019, and 2018 as follows (see Note 21 – Restructuring Initiatives for further details):
Year Ended December 31,202020192018
Restructuring Initiatives by Segment
Pharma$220 $632 $3,589 
Beauty + Home24,464 17,682 52,244 
Food + Beverage1,903 391 4,185 
Corporate & Other(95)1,767 3,811 
Total Restructuring Initiatives$26,492 $20,472 $63,829 
(4)Depreciation and amortization includes amortization related to acquisition purchase accounting adjustments. See the reconciliation of Non-U.S. GAAP measures.
(5)The transfer of corporate technology expenditures represents amounts of projects managed by corporate for the benefit of specific entities within each segment. Once the projects are complete, all related costs are allocated from corporate to and paid by the appropriate entity and the associated assets are then depreciated at the entity level.
Restructuring Initiatives
Year Ended December 31,202020192018
Restructuring Initiatives by Segment
Pharma$220 $632 $3,589 
Beauty + Home24,464 17,682 52,244 
Food + Beverage1,903 391 4,185 
Corporate & Other(95)1,767 3,811 
Total Restructuring Initiatives$26,492 $20,472 $63,829 
Schedule of net sales and long-lived asset information by geographic area
The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2020, 2019 and 2018:
202020192018
Net Sales to Unaffiliated Customers (1):
United States$965,986 $836,768 $726,336 
Europe:
France854,639 895,110 862,364 
Germany448,405 452,409 474,369 
Italy148,636 141,867 144,044 
Other Europe152,376 149,083 146,701 
Total Europe1,604,056 1,638,469 1,627,478 
Other Foreign Countries359,298 384,495 410,947 
Total$2,929,340 $2,859,732 $2,764,761 
Property, Plant and Equipment, Net
United States$298,616 $300,820 $265,004 
Europe:
France426,353 338,288 308,250 
Germany194,553 163,782 154,505 
Italy57,333 53,562 54,978 
Other Europe55,933 63,636 59,411 
Total Europe734,172 619,268 577,144 
Other Foreign Countries165,960 167,590 149,465 
Total$1,198,748 $1,087,678 $991,613 
(1)Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.